JCI Insight (Jul 2023)

A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection

  • Prashant Dogra,
  • Carmine Schiavone,
  • Zhihui Wang,
  • Javier Ruiz-Ramírez,
  • Sergio Caserta,
  • Daniela I. Staquicini,
  • Christopher Markosian,
  • Jin Wang,
  • H. Dirk Sostman,
  • Renata Pasqualini,
  • Wadih Arap,
  • Vittorio Cristini

Journal volume & issue
Vol. 8, no. 13

Abstract

Read online

While the development of different vaccines slowed the dissemination of SARS-CoV-2, the occurrence of breakthrough infections has continued to fuel the COVID-19 pandemic. To secure at least partial protection in the majority of the population through 1 dose of a COVID-19 vaccine, delayed administration of boosters has been implemented in many countries. However, waning immunity and emergence of new variants of SARS-CoV-2 suggest that such measures may induce breakthrough infections due to intermittent lapses in protection. Optimizing vaccine dosing schedules to ensure prolonged continuity in protection could thus help control the pandemic. We developed a mechanistic model of immune response to vaccines as an in silico tool for dosing schedule optimization. The model was calibrated with clinical data sets of acquired immunity to COVID-19 mRNA vaccines in healthy and immunocompromised participants and showed robust validation by accurately predicting neutralizing antibody kinetics in response to multiple doses of COVID-19 mRNA vaccines. Importantly, by estimating population vulnerability to breakthrough infections, we predicted tailored vaccination dosing schedules to minimize breakthrough infections, especially for immunocompromised individuals. We identified that the optimal vaccination schedules vary from CDC-recommended dosing, suggesting that the model is a valuable tool to optimize vaccine efficacy outcomes during future outbreaks.

Keywords